Report Detail

Medical Devices & Consumables Global Immunology-Oncology Elisa Kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4662395
  • |
  • 31 December, 2025
  • |
  • Global
  • |
  • 91 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Immunology-Oncology Elisa Kits market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Immunology-Oncology ELISA kits are laboratory tools used for the detection and quantification of specific proteins, antibodies, or biomarkers related to cancer (oncology) and immune system responses (immunology). These kits utilize the Enzyme-Linked Immunosorbent Assay (ELISA) technique, which is a highly sensitive and specific method used in immunology and cancer research to detect molecules like cytokines, tumor markers, or immune checkpoints. The kits are essential in diagnostics, research, and therapeutic development in oncology and immunology fields.
This report is a detailed and comprehensive analysis for global Immunology-Oncology Elisa Kits market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immunology-Oncology Elisa Kits market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Immunology-Oncology Elisa Kits market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Immunology-Oncology Elisa Kits market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Immunology-Oncology Elisa Kits market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immunology-Oncology Elisa Kits
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immunology-Oncology Elisa Kits market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Bio-Techne Corporation (R&D Systems), Abcam, BioLegend (part of PerkinElmer), BD Biosciences, MilliporeSigma (Merck KGaA), Enzo Life Sciences, RayBiotech Life, Inc., ELISAGEN Biotech, Creative Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Immunology-Oncology Elisa Kits market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Direct ELISA Kit
Indirect ELISA Kit
Market segment by Application
Cancer Diagnosis
Pharmaceutical Industry
Other
Major players covered
Thermo Fisher Scientific
Bio-Techne Corporation (R&D Systems)
Abcam
BioLegend (part of PerkinElmer)
BD Biosciences
MilliporeSigma (Merck KGaA)
Enzo Life Sciences
RayBiotech Life, Inc.
ELISAGEN Biotech
Creative Diagnostics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunology-Oncology Elisa Kits product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Immunology-Oncology Elisa Kits, with price, sales quantity, revenue, and global market share of Immunology-Oncology Elisa Kits from 2020 to 2025.
Chapter 3, the Immunology-Oncology Elisa Kits competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunology-Oncology Elisa Kits breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Immunology-Oncology Elisa Kits market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Immunology-Oncology Elisa Kits.
Chapter 14 and 15, to describe Immunology-Oncology Elisa Kits sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Immunology-Oncology Elisa Kits Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Direct ELISA Kit
    • 1.3.3 Indirect ELISA Kit
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Immunology-Oncology Elisa Kits Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Cancer Diagnosis
    • 1.4.3 Pharmaceutical Industry
    • 1.4.4 Other
  • 1.5 Global Immunology-Oncology Elisa Kits Market Size & Forecast
    • 1.5.1 Global Immunology-Oncology Elisa Kits Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Immunology-Oncology Elisa Kits Sales Quantity (2020-2031)
    • 1.5.3 Global Immunology-Oncology Elisa Kits Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product and Services
    • 2.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.2 Bio-Techne Corporation (R&D Systems)
    • 2.2.1 Bio-Techne Corporation (R&D Systems) Details
    • 2.2.2 Bio-Techne Corporation (R&D Systems) Major Business
    • 2.2.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product and Services
    • 2.2.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Bio-Techne Corporation (R&D Systems) Recent Developments/Updates
  • 2.3 Abcam
    • 2.3.1 Abcam Details
    • 2.3.2 Abcam Major Business
    • 2.3.3 Abcam Immunology-Oncology Elisa Kits Product and Services
    • 2.3.4 Abcam Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Abcam Recent Developments/Updates
  • 2.4 BioLegend (part of PerkinElmer)
    • 2.4.1 BioLegend (part of PerkinElmer) Details
    • 2.4.2 BioLegend (part of PerkinElmer) Major Business
    • 2.4.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product and Services
    • 2.4.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 BioLegend (part of PerkinElmer) Recent Developments/Updates
  • 2.5 BD Biosciences
    • 2.5.1 BD Biosciences Details
    • 2.5.2 BD Biosciences Major Business
    • 2.5.3 BD Biosciences Immunology-Oncology Elisa Kits Product and Services
    • 2.5.4 BD Biosciences Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 BD Biosciences Recent Developments/Updates
  • 2.6 MilliporeSigma (Merck KGaA)
    • 2.6.1 MilliporeSigma (Merck KGaA) Details
    • 2.6.2 MilliporeSigma (Merck KGaA) Major Business
    • 2.6.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product and Services
    • 2.6.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 MilliporeSigma (Merck KGaA) Recent Developments/Updates
  • 2.7 Enzo Life Sciences
    • 2.7.1 Enzo Life Sciences Details
    • 2.7.2 Enzo Life Sciences Major Business
    • 2.7.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Product and Services
    • 2.7.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Enzo Life Sciences Recent Developments/Updates
  • 2.8 RayBiotech Life, Inc.
    • 2.8.1 RayBiotech Life, Inc. Details
    • 2.8.2 RayBiotech Life, Inc. Major Business
    • 2.8.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product and Services
    • 2.8.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 RayBiotech Life, Inc. Recent Developments/Updates
  • 2.9 ELISAGEN Biotech
    • 2.9.1 ELISAGEN Biotech Details
    • 2.9.2 ELISAGEN Biotech Major Business
    • 2.9.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product and Services
    • 2.9.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 ELISAGEN Biotech Recent Developments/Updates
  • 2.10 Creative Diagnostics
    • 2.10.1 Creative Diagnostics Details
    • 2.10.2 Creative Diagnostics Major Business
    • 2.10.3 Creative Diagnostics Immunology-Oncology Elisa Kits Product and Services
    • 2.10.4 Creative Diagnostics Immunology-Oncology Elisa Kits Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Creative Diagnostics Recent Developments/Updates

3 Competitive Environment: Immunology-Oncology Elisa Kits by Manufacturer

  • 3.1 Global Immunology-Oncology Elisa Kits Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Immunology-Oncology Elisa Kits Revenue by Manufacturer (2020-2025)
  • 3.3 Global Immunology-Oncology Elisa Kits Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Immunology-Oncology Elisa Kits by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Immunology-Oncology Elisa Kits Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Immunology-Oncology Elisa Kits Manufacturer Market Share in 2024
  • 3.5 Immunology-Oncology Elisa Kits Market: Overall Company Footprint Analysis
    • 3.5.1 Immunology-Oncology Elisa Kits Market: Region Footprint
    • 3.5.2 Immunology-Oncology Elisa Kits Market: Company Product Type Footprint
    • 3.5.3 Immunology-Oncology Elisa Kits Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Immunology-Oncology Elisa Kits Market Size by Region
    • 4.1.1 Global Immunology-Oncology Elisa Kits Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Immunology-Oncology Elisa Kits Consumption Value by Region (2020-2031)
    • 4.1.3 Global Immunology-Oncology Elisa Kits Average Price by Region (2020-2031)
  • 4.2 North America Immunology-Oncology Elisa Kits Consumption Value (2020-2031)
  • 4.3 Europe Immunology-Oncology Elisa Kits Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Immunology-Oncology Elisa Kits Consumption Value (2020-2031)
  • 4.5 South America Immunology-Oncology Elisa Kits Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Immunology-Oncology Elisa Kits Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Immunology-Oncology Elisa Kits Sales Quantity by Type (2020-2031)
  • 5.2 Global Immunology-Oncology Elisa Kits Consumption Value by Type (2020-2031)
  • 5.3 Global Immunology-Oncology Elisa Kits Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Immunology-Oncology Elisa Kits Sales Quantity by Application (2020-2031)
  • 6.2 Global Immunology-Oncology Elisa Kits Consumption Value by Application (2020-2031)
  • 6.3 Global Immunology-Oncology Elisa Kits Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Immunology-Oncology Elisa Kits Sales Quantity by Type (2020-2031)
  • 7.2 North America Immunology-Oncology Elisa Kits Sales Quantity by Application (2020-2031)
  • 7.3 North America Immunology-Oncology Elisa Kits Market Size by Country
    • 7.3.1 North America Immunology-Oncology Elisa Kits Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Immunology-Oncology Elisa Kits Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Immunology-Oncology Elisa Kits Sales Quantity by Type (2020-2031)
  • 8.2 Europe Immunology-Oncology Elisa Kits Sales Quantity by Application (2020-2031)
  • 8.3 Europe Immunology-Oncology Elisa Kits Market Size by Country
    • 8.3.1 Europe Immunology-Oncology Elisa Kits Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Immunology-Oncology Elisa Kits Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Immunology-Oncology Elisa Kits Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Immunology-Oncology Elisa Kits Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Immunology-Oncology Elisa Kits Market Size by Region
    • 9.3.1 Asia-Pacific Immunology-Oncology Elisa Kits Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Immunology-Oncology Elisa Kits Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Immunology-Oncology Elisa Kits Sales Quantity by Type (2020-2031)
  • 10.2 South America Immunology-Oncology Elisa Kits Sales Quantity by Application (2020-2031)
  • 10.3 South America Immunology-Oncology Elisa Kits Market Size by Country
    • 10.3.1 South America Immunology-Oncology Elisa Kits Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Immunology-Oncology Elisa Kits Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Immunology-Oncology Elisa Kits Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Immunology-Oncology Elisa Kits Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Immunology-Oncology Elisa Kits Market Size by Country
    • 11.3.1 Middle East & Africa Immunology-Oncology Elisa Kits Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Immunology-Oncology Elisa Kits Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Immunology-Oncology Elisa Kits Market Drivers
  • 12.2 Immunology-Oncology Elisa Kits Market Restraints
  • 12.3 Immunology-Oncology Elisa Kits Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Immunology-Oncology Elisa Kits and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Immunology-Oncology Elisa Kits
  • 13.3 Immunology-Oncology Elisa Kits Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Immunology-Oncology Elisa Kits Typical Distributors
  • 14.3 Immunology-Oncology Elisa Kits Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Immunology-Oncology Elisa Kits. Industry analysis & Market Report on Immunology-Oncology Elisa Kits is a syndicated market report, published as Global Immunology-Oncology Elisa Kits Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Immunology-Oncology Elisa Kits market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report